Olopatadine Hydrochloride Solution/ Drops
FDA Label NDC 46708-709

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Alembic Pharmaceuticals Limited for the product Olopatadine Hydrochloride (NDC 46708-709). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient(s), purpose, use(s), warnings, do not use, when using this product, stop use and ask doctor if, keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredient(S)

Olopatadine (0.1%).........(equivalent to olopatadine hydrochloride 0.111%)

Purpose

Antihistamine and redness reliever

Use(S)

temporarily relieves itchy red eyes due to pollen, ragweed, grass, animal hair and dander

Warnings

For external use only

Do Not Use

• if solution changes color or becomes cloudy
• if you are sensitive to any ingredient in this product
• to treat contact lens related irritation


When Using This Product

• do not touch tip of container to any surface to avoid contamination
• remove contact lenses before use
• wait at least 10 minutes before reinserting contact lenses after use
• do not wear a contact lens if your eye is red


Stop Use And Ask Doctor If

you experience:


  • eye pain
  • changes in vision
  • increased redness of the eye
  • itching worsens or lasts for more than 72 hours

Keep Out Of Reach Of Children

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

• adults and children 2 years of age and older:
      • put 1 drop in the affected eye(s) twice daily, every 6 to 8 hours, no more than twice per day
      • if using other ophthalmic products while using this product, wait at least 5 minutes between each product
      • replace cap after each use
• children under 2 years of age: consult a doctor

Other Information

• only for use in the eye
• store between 4°C to 25°C (39°F to 77°F)


Inactive Ingredients

benzalkonium chloride 0.01%, dibasic sodium phosphate, hydrochloric acid/sodium hydroxide (adjust pH), sodium chloride, and water for Injection

Questions?

Contact Alembic Pharmaceuticals Inc. at 1-866-210-9797

Principal Display Panel

Olopatadine Hydrochloride Ophthalmic Solution 0.1%-Bottle Label: Alembic 

 

Olopatadine-container-f3-dpmfg (Olopatadine Container F3 Dpmfg)

Olopatadine-container-f3-dpmfg (Olopatadine Container F3 Dpmfg)

 

Olopatadine Hydrochloride Ophthalmic Solution 0.1%- Carton Label: Alembic

Olopatadine-carton-f3-dpmfg (Olopatadine Carton F3 Dpmfg)

Olopatadine-carton-f3-dpmfg (Olopatadine Carton F3 Dpmfg)

* Please review the disclaimer below.